2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
iShs Biotechnology (IBB)
NASDAQ
$211.25-$1.25 (-0.59%)
Price as of Nov 13, 2026 7:56 PM EST- 29.68%1-Year Change
iShs Biotechnology (IBB)
$211.25-$1.25 (-0.59%)
- 233Holdings Count
- $11.4BTotal Assets
- 51.29%Top 10 Percentage
Holdings
Holding | Latest Close | Shares Held | Weight %
| Market Value |
|---|---|---|---|---|
GILDGilead Sciences | $168.08 | 5.9M | 8.87% | $1.0B |
AMGNAmgen | $465.67 | 2.0M | 8.32% | $947.9M |
VRTXVertex Pharma | $538.60 | 1.6M | 7.68% | $874.5M |
REGNRegeneron Pharma | $955.47 | 763,426 | 6.43% | $732.4M |
MRNAMODERNA | $223.37 | 2.8M | 6.15% | $699.8M |
ARGXarGEN-X SpADR | $960.04 | 427,983 | 3.67% | $418.4M |
NTRANatera | $319.09 | 1.0M | 2.91% | $331.7M |
BIIBBiogen | $253.40 | 1.1M | 2.51% | $286.2M |
ONCBeOne Medi Sp ADR | $416.54 | 647,899 | 2.39% | $272.1M |
$172.29 | 1.5M | 2.36% | $268.3M | |
ILMNIllumina | $207.01 | 1.2M | 2.17% | $247.0M |
GMABGENMAB SP ADR | $51.37 | 4.3M | 2.02% | $229.8M |
INSMInsmed | $121.16 | 1.7M | 1.76% | $200.1M |
$591.17 | 319,334 | 1.67% | $190.2M | |
INCYIncyte | $120.97 | 1.5M | 1.66% | $189.2M |
ROIVROIVANT SCIENCES | $39.53 | 4.0M | 1.48% | $169.0M |
ALNYAlnylam Pharma | $165.04 | 1.0M | 1.44% | $164.2M |
NBIXNeurocrine Biosc | $167.40 | 774,066 | 1.19% | $135.0M |
EXELExelixis | $69.00 | 1.8M | 1.15% | $130.7M |
CRLCharles Riv Lab | $337.97 | 363,675 | 1.09% | $124.6M |
ASNDASCENDIS PHARMA BR | $275.39 | 475,583 | 1.08% | $123.3M |
MEDPMedpace Holdings | $653.94 | 173,116 | 1.01% | $115.1M |
BBIOBRIDGEBIO PHARMA | $78.30 | 1.3M | 0.94% | $107.3M |
HALOHalozyme Therape | $100.27 | 865,108 | 0.77% | $88.0M |
TECHBio-Techne | $72.80 | 1.2M | 0.77% | $87.5M |
BMRNBiomarin Pharm | $57.23 | 1.5M | 0.75% | $85.9M |
RGENRepligen | $167.79 | 462,002 | 0.70% | $79.8M |
KYMRKYMERA THERAP | $127.57 | 574,960 | 0.68% | $77.5M |
$63.37 | 1.1M | 0.67% | $76.8M | |
MDGLMadrigal Pharmct | $427.39 | 165,701 | 0.63% | $71.8M |
Holdings by Sector
- Healthcare100.00%